(Q31949243)

5 July 2017

title

Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes (English)

1 reference

5 July 2017

0 references

1 reference

Kinor N

1

1 reference

5 July 2017

Geffen R

2

1 reference

5 July 2017

Golomb E

3

1 reference

5 July 2017

Zinman T

4

1 reference

5 July 2017

Yadid G

5

1 reference

5 July 2017

publication date

1 February 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

33

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

143-150

1 reference

Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies.

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Biogenic amine-sensitive adenylate cyclases in primary culture of neuronal or glial cells from mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Dopaminergic neurons protected from degeneration by GDNF gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

21 January 2018

Gene therapy in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically-modified human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Glial receptors and their intervention in astrocyto-astrocytic and astrocyto-neuronal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Is there a ?dopaminergic glial cell??

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Mechanisms controlling gene expression by nuclear calcium signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Binding sites for [3H]dopamine and dopamine-antagonists on cultured astrocytes of rat striatum and spinal cord: an autoradiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Receptors on astrocytes--what possible functions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

GENETICALLY MODIFIED PRIMARY ASTROCYTES AS CELLULAR VEHICLES FOR GENE THERAPY IN THE BRAIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Long‐term production of neurotrophic factors by astrocyte cultures from hemiparkinsonian rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Establishment of a line of human fetal glial cells that supports JC virus multiplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Transmitter responsiveness in two newly isolated clones of neuroblastoma X glioma hybrid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

The use of nonneuronal cells for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1136%28200102%2933%3A2%3C143%3A%3AAID-GLIA1013%3E3.0.CO%3B2-3

10.1002/1098-1136(200102)33:2<143::AID-GLIA1013>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference